Serial Number
88979751
Owner
TEMPUS LABS, INC.Attorney
Amanda H. WilcoxFirst Use Date
May 15, 2020
Filing Date
Feb 4, 2020
TEMPUS Trademark
Serial Number: 88979751 • Registration: 6734166
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Amanda H. Wilcox TAFT STETTINIUS & HOLLISTER LLP
200 Public Square, Suite 3500
Cleveland, OH 44114
United States
Trademark Details
Filing Date
February 4, 2020
Registration Date
May 24, 2022
First Use Anywhere
May 15, 2020
First Use in Commerce
May 15, 2020
Published for Opposition
March 8, 2022
Goods & Services
Medical services in the field of neurology and depression diagnostics and testing; providing medical information in the fields of neurology and depression diagnostics and testing
Medical research in the fields of neurology and depression diagnostics and testing; medical and scientific research related to neurology and depression diagnostics and testing; providing medical and scientific research information in the fields of neurology and depression diagnostics and testing; medical and scientific research in the fields of neurology and depression diagnostics and testing; research and development services in the fields of neurology and depression diagnostics and testing; Computer system analysis for use in neurology and depression diagnostics and testing; computer system design for use in neurology and depression diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of neurology and depression diagnostics and testing; Platform as a service (PAAS) featuring computer software platforms for providing users with operating clinical decision-making support in the fields of neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software for providing users with clinical decision-making support in the fields of neurology, and depression diagnostics and testing; Platform as a service (PAAS) featuring computer software platforms for providing users with clinical decision-making support in the fields of neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software for machine learning using artificial intelligence features to support clinical data platforms in the fields of neurology, and depression diagnostics and testing; Platform as a service (PAAS) featuring computer software platforms for machine learning using artificial intelligence features to support clinical data platforms in the fields of neurology, and depression diagnostics and testing
